Forte Biosciences FBRX Stock
7.12 USD
{{ price }}
5.794946%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
46.86M USD
LOW - HIGH [24H]
6.7
-
7.41 USD
VOLUME [24H]
18.63K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-12.92 USD
Forte Biosciences Price Chart
Forte Biosciences FBRX Financial and Trading Overview
| Forte Biosciences stock price | 7.12 USD |
| Previous Close | 1.03 USD |
| Open | 1.03 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 3200 |
| Day's Range | 1.01 - 1.03 USD |
| 52 Week Range | 0.9 - 1.54 USD |
| Volume | 12.76K USD |
| Avg. Volume | 65.68K USD |
| Market Cap | 21.68M USD |
| Beta (5Y Monthly) | 1.391972 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.92 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.5 USD |
FBRX Valuation Measures
| Enterprise Value | -14219269 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.16194968 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.65688777 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Forte Biosciences Stock Price History
| Beta (5Y Monthly) | 1.391972 |
| 52-Week Change | -11.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.54 USD |
| 52 Week Low | 0.9 USD |
| 50-Day Moving Average | 1.04 USD |
| 200-Day Moving Average | 1.05 USD |
FBRX Share Statistics
| Avg. Volume (3 month) | 65.68K USD |
| Avg. Daily Volume (10-Days) | 15.77K USD |
| Shares Outstanding | 21.05M |
| Float | 12.91M |
| Short Ratio | 1.53 |
| % Held by Insiders | 18.56% |
| % Held by Institutions | 37.75% |
| Shares Short | 54.2K |
| Short % of Float | 0.27% |
| Short % of Shares Outstanding | 0.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.22% |
| Return on Equity (ttm) | -49.49% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -18065000 USD |
| Diluted EPS (ttm) | -0.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.9M USD |
| Total Cash Per Share (mrq) | 1.71 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.647 |
| Book Value Per Share (mrq) | 1.568 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11414000 USD |
| Levered Free Cash Flow (ttm) | -5050125 USD |
Profile of Forte Biosciences
| Country | United States |
| State | TX |
| City | Dallas |
| Address | 3060 Pegasus Park Drive |
| ZIP | 75247 |
| Phone | 310 618 6994 |
| Website | https://www.fortebiorx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Q&A For Forte Biosciences Stock
What is a current FBRX stock price?
Forte Biosciences FBRX stock price today per share is 7.12 USD.
How to purchase Forte Biosciences stock?
You can buy FBRX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Forte Biosciences?
The stock symbol or ticker of Forte Biosciences is FBRX.
Which industry does the Forte Biosciences company belong to?
The Forte Biosciences industry is Biotechnology.
How many shares does Forte Biosciences have in circulation?
The max supply of Forte Biosciences shares is 6.58M.
What is Forte Biosciences Price to Earnings Ratio (PE Ratio)?
Forte Biosciences PE Ratio is now.
What was Forte Biosciences earnings per share over the trailing 12 months (TTM)?
Forte Biosciences EPS is -12.92 USD over the trailing 12 months.
Which sector does the Forte Biosciences company belong to?
The Forte Biosciences sector is Healthcare.
Forte Biosciences FBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}